Dysregulation of junctional proteins controls Hippo/YAP pathway activity via specific mechanisms in liver cancer

Ähnliche Einträge

• Dysregulation of junctional proteins controls Hippo/YAP pathway activity via specific mechanisms in liver cancer
  von: Thiess, Lena
  Veröffentlicht: (2023)
• The common and distinct function of hippo pathway effectors yes-associated protein (yap) and ww domain containing transcription regulator 1 (taz) in liver development, regeneration and fibrosis
  von: Liu, Kaijing
  Veröffentlicht: (2020)
• Membrane palmitoylated protein 5 (MPP5),a novel upstream regulator of the hippo pathway in liver cancer
  von: Tóth, Marcell
  Veröffentlicht: (2020)
• Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma
  von: Berthold, Ruth, et al.
  Veröffentlicht: (2022)
• CRKL enhances YAP signaling through binding and JNK/JUN pathway activation in liver cancer
  von: Wesener, Marie C., et al.
  Veröffentlicht: (2024)